2009
DOI: 10.1080/13803390903313564
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive change in patients with Huntington disease on the Repeatable Battery for the Assessment of Neuropsychological Status

Abstract: Huntington disease (HD) is a neurodegenerative disease associated with cognitive, motor, and psychiatric deterioration over time. Although there is currently no cure for HD, there has been a surge of clinical trials available to patients with HD over the past 5 years. However, cognitive measures have generally been lacking from these trials. A brief, repeatable neuropsychological battery is needed to assess cognitive endpoints. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) may … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
30
1

Year Published

2010
2010
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 41 publications
(33 citation statements)
references
References 39 publications
2
30
1
Order By: Relevance
“…The total score for each item is obtained by multiplying frequency by severity. The UHDRS has been used in numerous studies of HD and randomized, controlled trials, either using the total score or specific item domains . A cutoff score of ≥6 for the presence of depressed mood was reported using the corresponding item of the UHDRS‐b .…”
Section: Scales Assessing Multiple Behavioral Domainsmentioning
confidence: 99%
“…The total score for each item is obtained by multiplying frequency by severity. The UHDRS has been used in numerous studies of HD and randomized, controlled trials, either using the total score or specific item domains . A cutoff score of ≥6 for the presence of depressed mood was reported using the corresponding item of the UHDRS‐b .…”
Section: Scales Assessing Multiple Behavioral Domainsmentioning
confidence: 99%
“…Huntington disease (HD) is a phenotypically heterogeneous disease characterized by choreiform and dystonic movements [1], bradykinesia [23], cognitive decline [4], and psychiatric comorbidities [5]. Balance and gait impairments [67], recurrent falls [89], and functional decline and disability [10] are common manifestations of the disease.…”
Section: Introductionmentioning
confidence: 99%
“…Test-retest reliability for the RBANS is adequate in geriatric samples (Duff et al, 2005). Although initially developed as a screening measure for dementia, the validity of the RBANS has been demonstrated in a variety of neuropsychological disorders (e.g., dementia, stroke, Parkinson’s disease, multiple sclerosis, Huntington’s disease, traumatic brain injury, depression) (Beatty, 2004; Beatty et al, 2003; Beglinger et al, 2009; Dickerson et al, 2004; Duff, Beglinger, Theriault, Allison, & Paulsen, 2009; Hobson, Hall, Humphreys-Clark, Schrimsher, & O’Bryant, 2009; Pachet, 2007; Paradiso, Duff, Vaidya, Hoth, & Mold, 2009; Wilde, 2006). …”
Section: Methodsmentioning
confidence: 99%